Ocular Chlamydia trachomatis infection: elimination with mass drug administration
- PMID: 30698042
- PMCID: PMC7155971
- DOI: 10.1080/14787210.2019.1577136
Ocular Chlamydia trachomatis infection: elimination with mass drug administration
Abstract
Ocular Chlamydia trachomatis infection, the causative agent for trachoma, is responsible for 1.9 million cases of visual loss worldwide. Mass Drug Administration (MDA) with azithromycin to entire trachoma-endemic districts is part of the World Health Organization's public health strategy for trachoma elimination. Areas covered: Background on C. trachomatis and the epidemiology of trachoma are presented, followed by a review of the antibiotics for treatment and the need for a public health approach to trachoma elimination. The effectiveness of mass drug administration is presented, concluding with challenges to trachoma elimination in the future. Expert opinion: MDA using azithromycin is a key component of the public health strategy for trachoma elimination. With high coverage in children, there is good evidence that MDA drops the community pool of infection. There are challenges to trachoma elimination by the year 2020, and the drug donation program for country MDAs will be integral to ongoing efforts.
Keywords: azithromycin; mass drug administration; review; trachoma.
Conflict of interest statement
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Figures
Similar articles
-
The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.Parasit Vectors. 2017 Dec 28;10(1):624. doi: 10.1186/s13071-017-2566-x. Parasit Vectors. 2017. PMID: 29282126 Free PMC article.
-
Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.Parasit Vectors. 2019 Oct 22;12(1):497. doi: 10.1186/s13071-019-3743-x. Parasit Vectors. 2019. PMID: 31640755 Free PMC article.
-
Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?J Infect Dis. 2014 Jul 1;210(1):65-71. doi: 10.1093/infdis/jiu046. Epub 2014 Jan 19. J Infect Dis. 2014. PMID: 24446528
-
Trachoma and antibiotic use: the 'A' in SAFE.Expert Rev Anti Infect Ther. 2012 Jan;10(1):75-83. doi: 10.1586/eri.11.150. Expert Rev Anti Infect Ther. 2012. PMID: 22149616 Review.
-
Antibiotics for trachoma.Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001860. doi: 10.1002/14651858.CD001860.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2019 Sep 26;9:CD001860. doi: 10.1002/14651858.CD001860.pub4 PMID: 21412875 Updated. Review.
Cited by
-
Ongoing transmission of trachoma in low prevalence districts in Mozambique: results from four cross-sectional enhanced impact surveys, 2022.Sci Rep. 2024 Oct 15;14(1):22842. doi: 10.1038/s41598-024-71201-z. Sci Rep. 2024. PMID: 39406720 Free PMC article.
-
Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial Schistosoma mansoni Infection Prevalence: A Cluster Randomized Trial.Am J Trop Med Hyg. 2020 Feb;102(2):318-327. doi: 10.4269/ajtmh.19-0626. Am J Trop Med Hyg. 2020. PMID: 31802733 Free PMC article. Clinical Trial.
-
Prevalence of Trachoma after Implementation of Trachoma Elimination Interventions in Oromia Regional State, Ethiopia: Results of Impact Surveys in 131 Evaluation Units Covering 139 Districts.Ophthalmic Epidemiol. 2023 Dec;30(6):647-654. doi: 10.1080/09286586.2022.2119257. Epub 2022 Dec 15. Ophthalmic Epidemiol. 2023. PMID: 36519534 Free PMC article.
-
Expanding a photographic grading system for trachomatous scarring.Int Health. 2023 Dec 4;15(Supplement_2):ii25-ii29. doi: 10.1093/inthealth/ihad078. Int Health. 2023. PMID: 38048380 Free PMC article.
-
Risk factors for the progression of trachomatous scarring in a cohort of women in a trachoma low endemic district in Tanzania.PLoS Negl Trop Dis. 2021 Nov 19;15(11):e0009914. doi: 10.1371/journal.pntd.0009914. eCollection 2021 Nov. PLoS Negl Trop Dis. 2021. PMID: 34797827 Free PMC article.
References
-
- World Health Organization. Global Elimination of Blinding Trachoma. In: World Health Assembly, editor. WHA5111 1998.
-
- Caldwell HD, Wood H, Crane D, Bailey R, Jones RB, Mabey D, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. The Journal of clinical investigation. 2003;111(11):1757–69. Epub 2003/06/05. doi: 10.1172/jci17993. - DOI - PMC - PubMed
-
An article that lays out how the biovars may differ, and explains the tissue tropism
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical